Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.54637229 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.54637229 |
3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.50077209 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.42758939 |
5 | L-phenylalanine metabolic process (GO:0006558) | 6.42758939 |
6 | urea metabolic process (GO:0019627) | 5.98910042 |
7 | urea cycle (GO:0000050) | 5.98910042 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 5.79843301 |
9 | nitrogen cycle metabolic process (GO:0071941) | 5.45366930 |
10 | high-density lipoprotein particle remodeling (GO:0034375) | 5.44131566 |
11 | kynurenine metabolic process (GO:0070189) | 5.34839177 |
12 | glyoxylate metabolic process (GO:0046487) | 5.20395696 |
13 | sulfur amino acid catabolic process (GO:0000098) | 5.16687758 |
14 | tryptophan catabolic process (GO:0006569) | 5.16635610 |
15 | indole-containing compound catabolic process (GO:0042436) | 5.16635610 |
16 | indolalkylamine catabolic process (GO:0046218) | 5.16635610 |
17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.12606019 |
18 | regulation of cholesterol esterification (GO:0010872) | 5.10109585 |
19 | regulation of triglyceride catabolic process (GO:0010896) | 5.04493404 |
20 | negative regulation of fibrinolysis (GO:0051918) | 5.01920888 |
21 | bile acid biosynthetic process (GO:0006699) | 4.98217980 |
22 | phospholipid efflux (GO:0033700) | 4.96011665 |
23 | homocysteine metabolic process (GO:0050667) | 4.93855465 |
24 | reverse cholesterol transport (GO:0043691) | 4.93825664 |
25 | acylglycerol homeostasis (GO:0055090) | 4.91870124 |
26 | triglyceride homeostasis (GO:0070328) | 4.91870124 |
27 | tryptophan metabolic process (GO:0006568) | 4.87260042 |
28 | protein-lipid complex remodeling (GO:0034368) | 4.85991277 |
29 | macromolecular complex remodeling (GO:0034367) | 4.85991277 |
30 | plasma lipoprotein particle remodeling (GO:0034369) | 4.85991277 |
31 | cysteine metabolic process (GO:0006534) | 4.82936609 |
32 | negative regulation of cholesterol transport (GO:0032375) | 4.79101427 |
33 | negative regulation of sterol transport (GO:0032372) | 4.79101427 |
34 | intestinal cholesterol absorption (GO:0030299) | 4.77887308 |
35 | drug catabolic process (GO:0042737) | 4.76043518 |
36 | regulation of fibrinolysis (GO:0051917) | 4.70097728 |
37 | L-serine metabolic process (GO:0006563) | 4.69004337 |
38 | bile acid metabolic process (GO:0008206) | 4.61040272 |
39 | bile acid and bile salt transport (GO:0015721) | 4.60638034 |
40 | serine family amino acid catabolic process (GO:0009071) | 4.56945009 |
41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.55550683 |
42 | protein carboxylation (GO:0018214) | 4.55550683 |
43 | plasma lipoprotein particle assembly (GO:0034377) | 4.51621332 |
44 | regulation of protein activation cascade (GO:2000257) | 4.51108009 |
45 | cellular ketone body metabolic process (GO:0046950) | 4.47568263 |
46 | lysine metabolic process (GO:0006553) | 4.46053149 |
47 | lysine catabolic process (GO:0006554) | 4.46053149 |
48 | amino-acid betaine metabolic process (GO:0006577) | 4.44146141 |
49 | cholesterol efflux (GO:0033344) | 4.42565372 |
50 | intestinal absorption (GO:0050892) | 4.41913023 |
51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.40325093 |
52 | plasma lipoprotein particle clearance (GO:0034381) | 4.37422353 |
53 | flavonoid metabolic process (GO:0009812) | 4.34442932 |
54 | complement activation, alternative pathway (GO:0006957) | 4.33141677 |
55 | aromatic amino acid family metabolic process (GO:0009072) | 4.25058832 |
56 | phospholipid homeostasis (GO:0055091) | 4.23106533 |
57 | regulation of bile acid biosynthetic process (GO:0070857) | 4.16793909 |
58 | cellular glucuronidation (GO:0052695) | 4.15065019 |
59 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.14528658 |
60 | regulation of complement activation (GO:0030449) | 4.14405649 |
61 | glycine metabolic process (GO:0006544) | 4.14208844 |
62 | alpha-amino acid catabolic process (GO:1901606) | 4.12919936 |
63 | cholesterol homeostasis (GO:0042632) | 4.07988463 |
64 | protein-lipid complex assembly (GO:0065005) | 4.06946779 |
65 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.06512605 |
66 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.06512605 |
67 | regulation of cholesterol homeostasis (GO:2000188) | 4.02507193 |
68 | sterol homeostasis (GO:0055092) | 4.01512508 |
69 | lipoprotein metabolic process (GO:0042157) | 3.98152594 |
70 | glutamate metabolic process (GO:0006536) | 3.97150984 |
71 | arginine metabolic process (GO:0006525) | 3.95616708 |
72 | serine family amino acid biosynthetic process (GO:0009070) | 3.92740349 |
73 | tyrosine metabolic process (GO:0006570) | 3.90609686 |
74 | low-density lipoprotein particle remodeling (GO:0034374) | 3.90037466 |
75 | cellular amino acid catabolic process (GO:0009063) | 3.86581525 |
76 | ethanol oxidation (GO:0006069) | 3.85545206 |
77 | serine family amino acid metabolic process (GO:0009069) | 3.85364094 |
78 | ketone body metabolic process (GO:1902224) | 3.84378570 |
79 | plasma lipoprotein particle organization (GO:0071827) | 3.83519495 |
80 | positive regulation of lipid catabolic process (GO:0050996) | 3.80204688 |
81 | benzene-containing compound metabolic process (GO:0042537) | 3.76155979 |
82 | cellular modified amino acid catabolic process (GO:0042219) | 3.75372115 |
83 | uronic acid metabolic process (GO:0006063) | 3.73609206 |
84 | glucuronate metabolic process (GO:0019585) | 3.73609206 |
85 | imidazole-containing compound metabolic process (GO:0052803) | 3.71966652 |
86 | short-chain fatty acid metabolic process (GO:0046459) | 3.70578699 |
87 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.67910793 |
88 | indolalkylamine metabolic process (GO:0006586) | 3.65597806 |
89 | protein-lipid complex subunit organization (GO:0071825) | 3.61973099 |
90 | aldehyde catabolic process (GO:0046185) | 3.60602970 |
91 | drug metabolic process (GO:0017144) | 3.54699850 |
92 | proline metabolic process (GO:0006560) | 3.53359946 |
93 | plasma membrane repair (GO:0001778) | 3.53233821 |
94 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.52589879 |
95 | exogenous drug catabolic process (GO:0042738) | 3.48636658 |
96 | cellular biogenic amine catabolic process (GO:0042402) | 3.45735834 |
97 | amine catabolic process (GO:0009310) | 3.45735834 |
98 | disruption of cells of other organism (GO:0044364) | 3.45263912 |
99 | killing of cells of other organism (GO:0031640) | 3.45263912 |
100 | carboxylic acid catabolic process (GO:0046395) | 3.45053953 |
101 | organic acid catabolic process (GO:0016054) | 3.45053953 |
102 | response to nitrosative stress (GO:0051409) | 3.44518274 |
103 | aspartate family amino acid catabolic process (GO:0009068) | 3.41541262 |
104 | regulation of plasminogen activation (GO:0010755) | 3.39451687 |
105 | proline biosynthetic process (GO:0006561) | 3.39199853 |
106 | NADH metabolic process (GO:0006734) | 3.22423646 |
107 | epoxygenase P450 pathway (GO:0019373) | 3.11764677 |
108 | blood coagulation, intrinsic pathway (GO:0007597) | 3.09670968 |
109 | fibrinolysis (GO:0042730) | 3.02692575 |
110 | tetrahydrofolate metabolic process (GO:0046653) | 3.02678146 |
111 | oxidative demethylation (GO:0070989) | 2.92672203 |
112 | omega-hydroxylase P450 pathway (GO:0097267) | 2.90158532 |
113 | establishment of integrated proviral latency (GO:0075713) | 2.89271540 |
114 | regulation of translational fidelity (GO:0006450) | 2.80977224 |
115 | regulation of sarcomere organization (GO:0060297) | 2.79688522 |
116 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.77668219 |
117 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.77202974 |
118 | polyketide metabolic process (GO:0030638) | 2.74375123 |
119 | doxorubicin metabolic process (GO:0044598) | 2.74375123 |
120 | daunorubicin metabolic process (GO:0044597) | 2.74375123 |
121 | ribosome assembly (GO:0042255) | 2.68044905 |
122 | negative regulation of protein localization to cell surface (GO:2000009) | 2.64240258 |
123 | DNA strand elongation (GO:0022616) | 2.63629101 |
124 | response to muscle activity (GO:0014850) | 2.63057676 |
125 | IMP biosynthetic process (GO:0006188) | 2.62381101 |
126 | tricarboxylic acid cycle (GO:0006099) | 2.57294718 |
127 | branched-chain amino acid catabolic process (GO:0009083) | 2.53500845 |
128 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.52330749 |
129 | folic acid-containing compound metabolic process (GO:0006760) | 2.51848404 |
130 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.49196910 |
131 | negative regulation of heart growth (GO:0061117) | 2.49196910 |
132 | biotin metabolic process (GO:0006768) | 2.48706906 |
133 | ribonucleoprotein complex disassembly (GO:0032988) | 2.48167016 |
134 | pteridine-containing compound metabolic process (GO:0042558) | 2.46106116 |
135 | alpha-amino acid biosynthetic process (GO:1901607) | 2.45018944 |
136 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.44510800 |
137 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.44450008 |
138 | IMP metabolic process (GO:0046040) | 2.44202857 |
139 | mitotic metaphase plate congression (GO:0007080) | 2.41524986 |
140 | oxaloacetate metabolic process (GO:0006107) | 2.40430858 |
141 | nucleobase biosynthetic process (GO:0046112) | 2.39278352 |
142 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.39212675 |
143 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.38748335 |
144 | DNA unwinding involved in DNA replication (GO:0006268) | 2.38719477 |
145 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.38525818 |
146 | protein localization to kinetochore (GO:0034501) | 2.38293135 |
147 | regulation of skeletal muscle contraction (GO:0014819) | 2.35244932 |
148 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.34792984 |
149 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.34792984 |
150 | phenylpropanoid metabolic process (GO:0009698) | 2.32926529 |
151 | glutamine family amino acid metabolic process (GO:0009064) | 2.32528678 |
152 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.31971289 |
153 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.30058057 |
154 | 4-hydroxyproline metabolic process (GO:0019471) | 2.29408485 |
155 | chromatin remodeling at centromere (GO:0031055) | 2.28235543 |
156 | tRNA aminoacylation for protein translation (GO:0006418) | 2.27760595 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.65735453 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.00025560 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.26897188 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.05007389 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.96093518 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.39367615 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.61215469 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.54268156 |
9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.90029504 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74774694 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.38450855 |
12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.35568895 |
13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.04423988 |
14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.94950857 |
15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.87531916 |
16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.76069507 |
17 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.64947979 |
18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.55769131 |
19 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.50378313 |
20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.43007462 |
21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.37815189 |
22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.34801338 |
23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.24831485 |
24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.13928924 |
25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.12862472 |
26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.12538037 |
27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.09974507 |
28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.08601635 |
29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.08180170 |
30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04268791 |
31 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.01330488 |
32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1796780 |
33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.93002213 |
34 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.91011146 |
35 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.89521169 |
36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88235604 |
37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.84869472 |
38 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.82946794 |
39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80961629 |
40 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.80223783 |
41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.77632221 |
42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.75781647 |
43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70890162 |
44 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.70633231 |
45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70347623 |
46 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.69805025 |
47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.67285820 |
48 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.65721452 |
49 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.63813925 |
50 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61193451 |
51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.58252747 |
52 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.56040031 |
53 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.55571868 |
54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55490840 |
55 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.55387519 |
56 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.51567668 |
57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50081852 |
58 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.49488606 |
59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.44312228 |
60 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.43593979 |
61 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.43105410 |
62 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.42680374 |
63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38722364 |
64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38306551 |
65 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38023427 |
66 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.38010594 |
67 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36576243 |
68 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33744758 |
69 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.31327377 |
70 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30092653 |
71 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26221638 |
72 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.25741109 |
73 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23846706 |
74 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.23750847 |
75 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.23113450 |
76 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.22683475 |
77 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21935126 |
78 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20493660 |
79 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.19591771 |
80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18335355 |
81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.17986074 |
82 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.15761192 |
83 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.14872944 |
84 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14566863 |
85 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14275381 |
86 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.13323318 |
87 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07121138 |
88 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07102603 |
89 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04690483 |
90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03392839 |
91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02944257 |
92 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02561348 |
93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02026167 |
94 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00007798 |
95 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.99722932 |
96 | * NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.99048276 |
97 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.96982419 |
98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96828731 |
99 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.96209794 |
100 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.95870435 |
101 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95733632 |
102 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.94174599 |
103 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94050220 |
104 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93149796 |
105 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.91547709 |
106 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.91547709 |
107 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.91547709 |
108 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91078809 |
109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90814322 |
110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90708856 |
111 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.90468701 |
112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89963731 |
113 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89578951 |
114 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.88926621 |
115 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88557001 |
116 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.88479814 |
117 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.88407099 |
118 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86851443 |
119 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86282509 |
120 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.84767401 |
121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84736347 |
122 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.84364710 |
123 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.82725642 |
124 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.78554926 |
125 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77736879 |
126 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.75576835 |
127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75253228 |
128 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73008114 |
129 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72959458 |
130 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72707183 |
131 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71188619 |
132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70023601 |
133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69442324 |
134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69394388 |
135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.67183806 |
136 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66890493 |
137 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66885032 |
138 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.66338701 |
139 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65486600 |
140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64959848 |
141 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64893574 |
142 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64623142 |
143 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.64407070 |
144 | ATF3_27146783_Chip-Seq_COLON_Human | 0.63564282 |
145 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.61915540 |
146 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.61375497 |
147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60468802 |
148 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.60427654 |
149 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59668676 |
150 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.59620108 |
151 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59136234 |
152 | GATA1_19941826_ChIP-Seq_K562_Human | 0.58573355 |
153 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.57322932 |
154 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.57261089 |
155 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56840914 |
156 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.56305575 |
157 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56285764 |
158 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.56034993 |
159 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.55006937 |
160 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54916067 |
161 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54139490 |
162 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.52656554 |
163 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.52112737 |
164 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51979538 |
165 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.51860883 |
166 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.50490925 |
167 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.50482794 |
168 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.50378052 |
169 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48304423 |
170 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.48182933 |
171 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.47634700 |
172 | AR_20517297_ChIP-Seq_VCAP_Human | 0.47063674 |
173 | P300_27268052_Chip-Seq_Bcells_Human | 0.46701122 |
174 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.46115751 |
175 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.45872169 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 8.16605117 |
2 | MP0002139_abnormal_hepatobiliary_system | 7.51673374 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.13833372 |
4 | MP0005365_abnormal_bile_salt | 5.69512664 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.62328015 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.19806428 |
7 | MP0003252_abnormal_bile_duct | 3.69817856 |
8 | MP0001666_abnormal_nutrient_absorption | 3.55306899 |
9 | MP0010329_abnormal_lipoprotein_level | 3.54208120 |
10 | MP0009840_abnormal_foam_cell | 3.47068854 |
11 | MP0003950_abnormal_plasma_membrane | 3.17721160 |
12 | MP0005083_abnormal_biliary_tract | 2.89852426 |
13 | MP0003941_abnormal_skin_development | 2.71719046 |
14 | MP0005332_abnormal_amino_acid | 2.55796876 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.32770775 |
16 | MP0003693_abnormal_embryo_hatching | 2.32215185 |
17 | MP0000749_muscle_degeneration | 2.17090763 |
18 | MP0008438_abnormal_cutaneous_collagen | 2.17010974 |
19 | MP0004019_abnormal_vitamin_homeostasis | 2.14886785 |
20 | MP0010030_abnormal_orbit_morphology | 2.07556446 |
21 | MP0004272_abnormal_basement_membrane | 2.06400198 |
22 | MP0010094_abnormal_chromosome_stability | 2.03910487 |
23 | MP0000609_abnormal_liver_physiology | 2.03634215 |
24 | MP0000751_myopathy | 2.00969167 |
25 | MP0003111_abnormal_nucleus_morphology | 1.98993692 |
26 | MP0004957_abnormal_blastocyst_morpholog | 1.92225149 |
27 | MP0003195_calcinosis | 1.91780932 |
28 | MP0002118_abnormal_lipid_homeostasis | 1.88190507 |
29 | MP0003868_abnormal_feces_composition | 1.81609758 |
30 | MP0005319_abnormal_enzyme/_coenzyme | 1.77398073 |
31 | MP0008058_abnormal_DNA_repair | 1.73654194 |
32 | MP0002138_abnormal_hepatobiliary_system | 1.68928981 |
33 | MP0004264_abnormal_extraembryonic_tissu | 1.56238989 |
34 | MP0001764_abnormal_homeostasis | 1.54840871 |
35 | MP0009697_abnormal_copulation | 1.50645959 |
36 | MP0008932_abnormal_embryonic_tissue | 1.48050498 |
37 | MP0006292_abnormal_olfactory_placode | 1.47415489 |
38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43568856 |
39 | MP0003705_abnormal_hypodermis_morpholog | 1.42496729 |
40 | MP0009643_abnormal_urine_homeostasis | 1.42142435 |
41 | MP0005451_abnormal_body_composition | 1.38231795 |
42 | MP0004145_abnormal_muscle_electrophysio | 1.37817402 |
43 | MP0002269_muscular_atrophy | 1.29733334 |
44 | MP0001293_anophthalmia | 1.29608268 |
45 | MP0003077_abnormal_cell_cycle | 1.28880299 |
46 | MP0010234_abnormal_vibrissa_follicle | 1.28547163 |
47 | MP0002938_white_spotting | 1.27563844 |
48 | MP0005623_abnormal_meninges_morphology | 1.20339356 |
49 | MP0001873_stomach_inflammation | 1.14473586 |
50 | MP0002697_abnormal_eye_size | 1.11951566 |
51 | MP0002822_catalepsy | 1.11446018 |
52 | MP0001730_embryonic_growth_arrest | 1.11407881 |
53 | MP0005084_abnormal_gallbladder_morpholo | 1.11402088 |
54 | MP0000598_abnormal_liver_morphology | 1.11278526 |
55 | MP0004233_abnormal_muscle_weight | 1.10582491 |
56 | MP0003937_abnormal_limbs/digits/tail_de | 1.06928475 |
57 | MP0003566_abnormal_cell_adhesion | 1.03910282 |
58 | MP0008007_abnormal_cellular_replicative | 1.02585853 |
59 | MP0003656_abnormal_erythrocyte_physiolo | 1.02156963 |
60 | MP0003567_abnormal_fetal_cardiomyocyte | 1.01450044 |
61 | MP0001915_intracranial_hemorrhage | 0.99312337 |
62 | MP0006036_abnormal_mitochondrial_physio | 0.98745765 |
63 | MP0005257_abnormal_intraocular_pressure | 0.98217986 |
64 | MP0001663_abnormal_digestive_system | 0.96795097 |
65 | MP0003123_paternal_imprinting | 0.96363683 |
66 | MP0000604_amyloidosis | 0.96233888 |
67 | MP0004087_abnormal_muscle_fiber | 0.96186132 |
68 | MP0005636_abnormal_mineral_homeostasis | 0.95973797 |
69 | MP0000462_abnormal_digestive_system | 0.95397635 |
70 | MP0002254_reproductive_system_inflammat | 0.95250930 |
71 | MP0010155_abnormal_intestine_physiology | 0.94943671 |
72 | MP0003186_abnormal_redox_activity | 0.94476580 |
73 | MP0005395_other_phenotype | 0.93953971 |
74 | MP0003300_gastrointestinal_ulcer | 0.92963456 |
75 | MP0002102_abnormal_ear_morphology | 0.90491681 |
76 | MP0008469_abnormal_protein_level | 0.89275971 |
77 | MP0000566_synostosis | 0.89275488 |
78 | MP0002089_abnormal_postnatal_growth/wei | 0.88826050 |
79 | MP0009763_increased_sensitivity_to | 0.88008981 |
80 | MP0009642_abnormal_blood_homeostasis | 0.87536167 |
81 | MP0000467_abnormal_esophagus_morphology | 0.87525571 |
82 | MP0002233_abnormal_nose_morphology | 0.86098266 |
83 | MP0003315_abnormal_perineum_morphology | 0.85183356 |
84 | MP0003011_delayed_dark_adaptation | 0.83007624 |
85 | MP0002106_abnormal_muscle_physiology | 0.82859183 |
86 | MP0009780_abnormal_chondrocyte_physiolo | 0.82604784 |
87 | MP0000762_abnormal_tongue_morphology | 0.82311504 |
88 | MP0002108_abnormal_muscle_morphology | 0.81172618 |
89 | MP0000759_abnormal_skeletal_muscle | 0.80770499 |
90 | MP0005381_digestive/alimentary_phenotyp | 0.80759014 |
91 | MP0002085_abnormal_embryonic_tissue | 0.80183608 |
92 | MP0003385_abnormal_body_wall | 0.79386074 |
93 | MP0005369_muscle_phenotype | 0.78397367 |
94 | MP0000750_abnormal_muscle_regeneration | 0.78254515 |
95 | MP0002092_abnormal_eye_morphology | 0.78047869 |
96 | MP0009764_decreased_sensitivity_to | 0.77983939 |
97 | MP0002282_abnormal_trachea_morphology | 0.77803500 |
98 | MP0005220_abnormal_exocrine_pancreas | 0.77626119 |
99 | MP0001299_abnormal_eye_distance/ | 0.77470101 |
100 | MP0005376_homeostasis/metabolism_phenot | 0.76862368 |
101 | MP0002163_abnormal_gland_morphology | 0.76330995 |
102 | MP0005408_hypopigmentation | 0.76206916 |
103 | MP0001697_abnormal_embryo_size | 0.76149558 |
104 | MP0001286_abnormal_eye_development | 0.76077969 |
105 | MP0005448_abnormal_energy_balance | 0.74713291 |
106 | MP0000350_abnormal_cell_proliferation | 0.74524642 |
107 | MP0002249_abnormal_larynx_morphology | 0.73552556 |
108 | MP0005266_abnormal_metabolism | 0.73535156 |
109 | MP0003942_abnormal_urinary_system | 0.73275410 |
110 | MP0000747_muscle_weakness | 0.73256300 |
111 | MP0000049_abnormal_middle_ear | 0.73026932 |
112 | MP0002078_abnormal_glucose_homeostasis | 0.72875440 |
113 | MP0002084_abnormal_developmental_patter | 0.72449274 |
114 | MP0002234_abnormal_pharynx_morphology | 0.71838295 |
115 | MP0009250_abnormal_appendicular_skeleto | 0.71399735 |
116 | MP0009765_abnormal_xenobiotic_induced | 0.71167607 |
117 | MP0002080_prenatal_lethality | 0.70905936 |
118 | MP0003119_abnormal_digestive_system | 0.70789404 |
119 | MP0005197_abnormal_uvea_morphology | 0.70453966 |
120 | MP0001672_abnormal_embryogenesis/_devel | 0.69467600 |
121 | MP0003866_abnormal_defecation | 0.67765396 |
122 | MP0009053_abnormal_anal_canal | 0.67425389 |
123 | MP0002837_dystrophic_cardiac_calcinosis | 0.65618584 |
124 | MP0000477_abnormal_intestine_morphology | 0.64389901 |
125 | MP0006035_abnormal_mitochondrial_morpho | 0.64202772 |
126 | MP0005647_abnormal_sex_gland | 0.61317157 |
127 | MP0008872_abnormal_physiological_respon | 0.61213277 |
128 | MP0008004_abnormal_stomach_pH | 0.60670942 |
129 | MP0001756_abnormal_urination | 0.60176882 |
130 | MP0010368_abnormal_lymphatic_system | 0.58480233 |
131 | MP0002971_abnormal_brown_adipose | 0.54479676 |
132 | MP0002136_abnormal_kidney_physiology | 0.53532732 |
133 | MP0004130_abnormal_muscle_cell | 0.52692628 |
134 | MP0005166_decreased_susceptibility_to | 0.51577057 |
135 | MP0005334_abnormal_fat_pad | 0.51490943 |
136 | MP0005464_abnormal_platelet_physiology | 0.50311503 |
137 | MP0005167_abnormal_blood-brain_barrier | 0.50153711 |
138 | MP0002796_impaired_skin_barrier | 0.49948116 |
139 | MP0003329_amyloid_beta_deposits | 0.49460090 |
140 | MP0004782_abnormal_surfactant_physiolog | 0.48815331 |
141 | MP0000490_abnormal_crypts_of | 0.48165898 |
142 | MP0010352_gastrointestinal_tract_polyps | 0.48067954 |
143 | MP0008873_increased_physiological_sensi | 0.47696617 |
144 | MP0001845_abnormal_inflammatory_respons | 0.45622282 |
145 | MP0003718_maternal_effect | 0.44580419 |
146 | MP0002876_abnormal_thyroid_physiology | 0.43698445 |
147 | MP0005330_cardiomyopathy | 0.42939591 |
148 | MP0003953_abnormal_hormone_level | 0.41552243 |
149 | MP0005535_abnormal_body_temperature | 0.41411521 |
150 | MP0003638_abnormal_response/metabolism_ | 0.40002091 |
151 | MP0000538_abnormal_urinary_bladder | 0.39977387 |
152 | MP0009379_abnormal_foot_pigmentation | 0.39640906 |
153 | MP0009384_cardiac_valve_regurgitation | 0.38435247 |
154 | MP0003724_increased_susceptibility_to | 0.37974448 |
155 | MP0000639_abnormal_adrenal_gland | 0.37934903 |
156 | MP0000537_abnormal_urethra_morphology | 0.37756294 |
157 | MP0001664_abnormal_digestion | 0.36003194 |
158 | MP0009672_abnormal_birth_weight | 0.35961170 |
159 | MP0004147_increased_porphyrin_level | 0.35460033 |
160 | MP0001661_extended_life_span | 0.35274744 |
161 | MP0003436_decreased_susceptibility_to | 0.34505860 |
162 | MP0004947_skin_inflammation | 0.33231697 |
163 | MP0000249_abnormal_blood_vessel | 0.32891986 |
164 | MP0001765_abnormal_ion_homeostasis | 0.31730546 |
165 | MP0005187_abnormal_penis_morphology | 0.31290600 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypobetalipoproteinemia (HP:0003563) | 6.70706986 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.59384420 |
3 | Deep venous thrombosis (HP:0002625) | 6.43722690 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.27102393 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.17901315 |
6 | Xanthomatosis (HP:0000991) | 5.62413168 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.34474457 |
8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.85453949 |
9 | Hyperammonemia (HP:0001987) | 4.85132946 |
10 | Hypolipoproteinemia (HP:0010981) | 4.71399115 |
11 | Ketosis (HP:0001946) | 4.20462062 |
12 | Fat malabsorption (HP:0002630) | 4.20362575 |
13 | Hyperlipoproteinemia (HP:0010980) | 4.15605295 |
14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.13783402 |
15 | Increased serum pyruvate (HP:0003542) | 4.13401281 |
16 | Exercise-induced muscle cramps (HP:0003710) | 4.12356717 |
17 | Conjugated hyperbilirubinemia (HP:0002908) | 4.11608025 |
18 | Abnormality of glycolysis (HP:0004366) | 4.10919722 |
19 | Hypoglycemic coma (HP:0001325) | 4.09690172 |
20 | Complement deficiency (HP:0004431) | 4.00251884 |
21 | Epidermoid cyst (HP:0200040) | 3.96950529 |
22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.92952198 |
23 | Joint hemorrhage (HP:0005261) | 3.89411158 |
24 | Exercise-induced myalgia (HP:0003738) | 3.84743193 |
25 | Hyperglycinuria (HP:0003108) | 3.83939393 |
26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.82222813 |
27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.81743025 |
28 | Hyperglycinemia (HP:0002154) | 3.76920771 |
29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.71272970 |
30 | Abnormality of glycine metabolism (HP:0010895) | 3.71272970 |
31 | Calf muscle hypertrophy (HP:0008981) | 3.65787385 |
32 | Ketoacidosis (HP:0001993) | 3.65250121 |
33 | Hypercholesterolemia (HP:0003124) | 3.61021463 |
34 | Hypoalphalipoproteinemia (HP:0003233) | 3.57055983 |
35 | Acanthocytosis (HP:0001927) | 3.49720795 |
36 | Abnormality of methionine metabolism (HP:0010901) | 3.48417944 |
37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.43791623 |
38 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.35768479 |
39 | Hyperbilirubinemia (HP:0002904) | 3.32732998 |
40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.26901874 |
41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.25259609 |
42 | Late onset (HP:0003584) | 3.20739750 |
43 | Nemaline bodies (HP:0003798) | 3.15183126 |
44 | Abnormality of the intrinsic pathway (HP:0010989) | 3.12877099 |
45 | Ileus (HP:0002595) | 3.07662753 |
46 | Abnormality of complement system (HP:0005339) | 3.00468027 |
47 | Malnutrition (HP:0004395) | 2.92878436 |
48 | Premature rupture of membranes (HP:0001788) | 2.90147845 |
49 | Dicarboxylic aciduria (HP:0003215) | 2.88957347 |
50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.88957347 |
51 | Abnormality of nucleobase metabolism (HP:0010932) | 2.87199002 |
52 | Metabolic acidosis (HP:0001942) | 2.86397557 |
53 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.85440807 |
54 | Muscle fiber inclusion bodies (HP:0100299) | 2.81307127 |
55 | Muscle stiffness (HP:0003552) | 2.80685580 |
56 | Lethargy (HP:0001254) | 2.75782015 |
57 | Hepatocellular carcinoma (HP:0001402) | 2.73261757 |
58 | Cerebral edema (HP:0002181) | 2.69596721 |
59 | Round ear (HP:0100830) | 2.66901426 |
60 | Abnormality of serum amino acid levels (HP:0003112) | 2.61883975 |
61 | Steatorrhea (HP:0002570) | 2.60229429 |
62 | Abnormality of purine metabolism (HP:0004352) | 2.58902692 |
63 | Spontaneous abortion (HP:0005268) | 2.54788296 |
64 | Hypoglycemic seizures (HP:0002173) | 2.51728812 |
65 | Delayed CNS myelination (HP:0002188) | 2.50828825 |
66 | Esophageal varix (HP:0002040) | 2.50643494 |
67 | Right ventricular cardiomyopathy (HP:0011663) | 2.49447927 |
68 | Skin nodule (HP:0200036) | 2.49015240 |
69 | Poikilocytosis (HP:0004447) | 2.46354844 |
70 | Protrusio acetabuli (HP:0003179) | 2.44504412 |
71 | Spastic diplegia (HP:0001264) | 2.31572254 |
72 | Cholecystitis (HP:0001082) | 2.30665809 |
73 | Abnormal gallbladder physiology (HP:0012438) | 2.30665809 |
74 | Myocardial infarction (HP:0001658) | 2.30290203 |
75 | Reduced antithrombin III activity (HP:0001976) | 2.29362587 |
76 | Cholelithiasis (HP:0001081) | 2.27584492 |
77 | Abnormal gallbladder morphology (HP:0012437) | 2.27349234 |
78 | Glycosuria (HP:0003076) | 2.24094462 |
79 | Abnormality of urine glucose concentration (HP:0011016) | 2.24094462 |
80 | Vascular calcification (HP:0004934) | 2.23150048 |
81 | Irritability (HP:0000737) | 2.20547356 |
82 | Hydroxyprolinuria (HP:0003080) | 2.20375310 |
83 | Abnormality of proline metabolism (HP:0010907) | 2.20375310 |
84 | Myotonia (HP:0002486) | 2.19987749 |
85 | Pterygium (HP:0001059) | 2.18490895 |
86 | Vomiting (HP:0002013) | 2.17702043 |
87 | Type 1 muscle fiber predominance (HP:0003803) | 2.17235369 |
88 | Pancreatitis (HP:0001733) | 2.15206013 |
89 | Glomerulonephritis (HP:0000099) | 2.14914314 |
90 | Symptomatic seizures (HP:0011145) | 2.14884253 |
91 | Abnormality of vitamin metabolism (HP:0100508) | 2.13168606 |
92 | Hypochromic microcytic anemia (HP:0004840) | 2.12679391 |
93 | Popliteal pterygium (HP:0009756) | 2.12215574 |
94 | Nausea (HP:0002018) | 2.11811897 |
95 | Systemic lupus erythematosus (HP:0002725) | 2.10597719 |
96 | Neonatal onset (HP:0003623) | 2.10235931 |
97 | Abnormality of the calf musculature (HP:0001430) | 2.07085056 |
98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07032268 |
99 | Abnormal cartilage morphology (HP:0002763) | 2.06392808 |
100 | Amyloidosis (HP:0011034) | 2.06268907 |
101 | Subaortic stenosis (HP:0001682) | 2.05612307 |
102 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.05612307 |
103 | Gingival bleeding (HP:0000225) | 2.03563889 |
104 | Proximal tubulopathy (HP:0000114) | 2.01855638 |
105 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.00038132 |
106 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.00038132 |
107 | Gout (HP:0001997) | 1.99008321 |
108 | Generalized aminoaciduria (HP:0002909) | 1.97830835 |
109 | Cardiovascular calcification (HP:0011915) | 1.96397273 |
110 | Abnormality of the gallbladder (HP:0005264) | 1.90282153 |
111 | Palpitations (HP:0001962) | 1.89851941 |
112 | Ragged-red muscle fibers (HP:0003200) | 1.89518576 |
113 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88923369 |
114 | Sensorimotor neuropathy (HP:0007141) | 1.88656126 |
115 | Alkalosis (HP:0001948) | 1.88503086 |
116 | Reticulocytosis (HP:0001923) | 1.87204339 |
117 | Hepatic necrosis (HP:0002605) | 1.86985316 |
118 | Mitral stenosis (HP:0001718) | 1.85256848 |
119 | Thrombophlebitis (HP:0004418) | 1.84661954 |
120 | Ventricular fibrillation (HP:0001663) | 1.83098758 |
121 | Neck muscle weakness (HP:0000467) | 1.81847246 |
122 | Opisthotonus (HP:0002179) | 1.81594296 |
123 | Abnormality of placental membranes (HP:0011409) | 1.81308273 |
124 | Amniotic constriction ring (HP:0009775) | 1.81308273 |
125 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.78484984 |
126 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.75355334 |
127 | Abnormal delivery (HP:0001787) | 1.74172901 |
128 | Gowers sign (HP:0003391) | 1.69231095 |
129 | Poor suck (HP:0002033) | 1.68629976 |
130 | Back pain (HP:0003418) | 1.68271810 |
131 | Aortic dissection (HP:0002647) | 1.67027304 |
132 | Calcaneovalgus deformity (HP:0001848) | 1.66960459 |
133 | Acute encephalopathy (HP:0006846) | 1.66936997 |
134 | Abnormality of the Achilles tendon (HP:0005109) | 1.66561570 |
135 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.65643813 |
136 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.65421931 |
137 | Chromsome breakage (HP:0040012) | 1.65251575 |
138 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.64766591 |
139 | Abnormality of the umbilical cord (HP:0010881) | 1.62984943 |
140 | Rhabdomyolysis (HP:0003201) | 1.58409872 |
141 | Multiple enchondromatosis (HP:0005701) | 1.58023164 |
142 | Arterial tortuosity (HP:0005116) | 1.56395282 |
143 | Dry hair (HP:0011359) | 1.55754340 |
144 | Myopathic facies (HP:0002058) | 1.55722447 |
145 | Ependymoma (HP:0002888) | 1.55408388 |
146 | Renal cortical cysts (HP:0000803) | 1.54307639 |
147 | Progressive muscle weakness (HP:0003323) | 1.54295088 |
148 | Meckel diverticulum (HP:0002245) | 1.54247945 |
149 | Deformed tarsal bones (HP:0008119) | 1.53172974 |
150 | Increased nuchal translucency (HP:0010880) | 1.52004016 |
151 | Type 2 muscle fiber atrophy (HP:0003554) | 1.51414341 |
152 | Neoplasm of the adrenal gland (HP:0100631) | 1.49736005 |
153 | Microvesicular hepatic steatosis (HP:0001414) | 1.49453612 |
154 | Decreased muscle mass (HP:0003199) | 1.48654460 |
155 | Trismus (HP:0000211) | 1.48213572 |
156 | Distal arthrogryposis (HP:0005684) | 1.47826198 |
157 | Muscle fiber atrophy (HP:0100295) | 1.45317781 |
158 | Abnormality of the ileum (HP:0001549) | 1.45273948 |
159 | Small epiphyses (HP:0010585) | 1.44250311 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.05665766 |
2 | PKN2 | 4.22189252 |
3 | LMTK2 | 3.91374172 |
4 | BUB1 | 3.54754216 |
5 | ERN1 | 3.50521634 |
6 | VRK2 | 3.43311976 |
7 | MST1R | 3.35504343 |
8 | FGFR4 | 3.30698712 |
9 | MAP3K10 | 2.85871529 |
10 | TRIB3 | 2.82533600 |
11 | FRK | 2.77750835 |
12 | SIK1 | 2.72257977 |
13 | TAF1 | 2.63641252 |
14 | CDC7 | 2.54898640 |
15 | EIF2AK1 | 2.45949008 |
16 | MUSK | 2.43881424 |
17 | PTK6 | 2.36174390 |
18 | SMG1 | 2.27316482 |
19 | GRK6 | 2.27143546 |
20 | TAOK3 | 2.22934686 |
21 | MAPKAPK5 | 2.18843080 |
22 | MAP2K2 | 2.17511565 |
23 | SRPK1 | 2.04673283 |
24 | MAPK11 | 1.93751799 |
25 | FLT3 | 1.93561701 |
26 | TSSK6 | 1.92939107 |
27 | CCNB1 | 1.84820662 |
28 | PLK3 | 1.83616626 |
29 | EIF2AK3 | 1.74633749 |
30 | ZAK | 1.72034676 |
31 | PRKG2 | 1.70803678 |
32 | INSRR | 1.69124848 |
33 | MAP2K6 | 1.68357980 |
34 | CDK8 | 1.62689918 |
35 | NEK2 | 1.57575875 |
36 | MYLK | 1.54177680 |
37 | STK16 | 1.53754712 |
38 | TTN | 1.52595000 |
39 | OBSCN | 1.51119094 |
40 | TBK1 | 1.49694266 |
41 | VRK1 | 1.49669645 |
42 | RIPK1 | 1.46224317 |
43 | ERBB4 | 1.39667403 |
44 | MAP3K11 | 1.35785983 |
45 | BRSK2 | 1.34618068 |
46 | EPHA2 | 1.31011233 |
47 | WEE1 | 1.30805104 |
48 | TYK2 | 1.27980039 |
49 | LIMK1 | 1.26188940 |
50 | DMPK | 1.25315138 |
51 | PLK1 | 1.24591626 |
52 | MKNK1 | 1.17979491 |
53 | MKNK2 | 1.17129658 |
54 | NEK1 | 1.15987940 |
55 | KDR | 1.15796332 |
56 | ERBB2 | 1.12681899 |
57 | PAK2 | 1.11907864 |
58 | PBK | 1.11419946 |
59 | CHEK2 | 1.10196290 |
60 | DAPK2 | 1.09308499 |
61 | PLK4 | 1.07978142 |
62 | PIK3CG | 1.05665403 |
63 | PIK3CA | 1.04943521 |
64 | LATS2 | 1.04696334 |
65 | MET | 1.04068657 |
66 | MAP3K7 | 1.04026537 |
67 | AURKB | 1.03184680 |
68 | CDK7 | 1.02080604 |
69 | LATS1 | 1.00949137 |
70 | PRKAA2 | 0.97673036 |
71 | EIF2AK2 | 0.94875732 |
72 | STK3 | 0.93744053 |
73 | MAP2K4 | 0.93632893 |
74 | BRSK1 | 0.89049049 |
75 | AURKA | 0.88301032 |
76 | NUAK1 | 0.86812266 |
77 | MAP3K3 | 0.84825662 |
78 | PDK3 | 0.83589036 |
79 | PDK4 | 0.83589036 |
80 | PTK2 | 0.83150210 |
81 | ATR | 0.82834132 |
82 | MAP2K1 | 0.82745374 |
83 | WNK3 | 0.82382794 |
84 | ABL2 | 0.79479479 |
85 | CSK | 0.78652656 |
86 | MELK | 0.77836420 |
87 | NEK9 | 0.76555212 |
88 | FGFR1 | 0.76528810 |
89 | EPHB2 | 0.76427687 |
90 | EEF2K | 0.76034769 |
91 | CDK4 | 0.75876853 |
92 | JAK2 | 0.75735820 |
93 | WNK4 | 0.75214886 |
94 | MAP3K2 | 0.73453564 |
95 | CDK9 | 0.72066519 |
96 | MAP3K8 | 0.70649681 |
97 | PDPK1 | 0.70472607 |
98 | MAP4K1 | 0.69531589 |
99 | PRKACG | 0.68463456 |
100 | TRIM28 | 0.66952602 |
101 | MAPK4 | 0.66821794 |
102 | CAMK1D | 0.65606239 |
103 | CSNK1G1 | 0.64721558 |
104 | NME2 | 0.64589151 |
105 | PHKG2 | 0.64234647 |
106 | PHKG1 | 0.64234647 |
107 | KSR2 | 0.63737870 |
108 | PRKAA1 | 0.61444233 |
109 | CHEK1 | 0.60034787 |
110 | CDK6 | 0.57884828 |
111 | CAMK2G | 0.57617229 |
112 | DYRK1B | 0.57003384 |
113 | MAP2K3 | 0.56384769 |
114 | CSNK1G3 | 0.55899661 |
115 | ALK | 0.55355412 |
116 | PDK1 | 0.54856531 |
117 | PRKCZ | 0.54134183 |
118 | TTK | 0.53439227 |
119 | STK39 | 0.53397039 |
120 | SCYL2 | 0.53017884 |
121 | CSNK2A2 | 0.51297508 |
122 | CSNK1E | 0.50501032 |
123 | TNIK | 0.50452595 |
124 | ICK | 0.50295535 |
125 | ATM | 0.49881239 |
126 | STK38L | 0.49761842 |
127 | MST4 | 0.49674700 |
128 | DYRK2 | 0.49654087 |
129 | EPHB1 | 0.49379002 |
130 | ILK | 0.49154792 |
131 | BCR | 0.46993981 |
132 | MAP3K1 | 0.46986297 |
133 | PRKCQ | 0.46448487 |
134 | CSNK2A1 | 0.45314235 |
135 | PIM2 | 0.44312661 |
136 | IKBKE | 0.43965406 |
137 | GSK3A | 0.43834609 |
138 | MATK | 0.43058846 |
139 | DAPK3 | 0.42883505 |
140 | LRRK2 | 0.42807213 |
141 | TAOK1 | 0.42640169 |
142 | BLK | 0.42463635 |
143 | TESK1 | 0.42177209 |
144 | ACVR1B | 0.42151638 |
145 | CDK1 | 0.42027631 |
146 | CSNK1A1L | 0.41677668 |
147 | PRKCI | 0.40619692 |
148 | TGFBR1 | 0.40225082 |
149 | DAPK1 | 0.38215696 |
150 | RPS6KB2 | 0.37757334 |
151 | JAK1 | 0.37675978 |
152 | PAK4 | 0.36026858 |
153 | MAP3K5 | 0.35845129 |
154 | NME1 | 0.35265713 |
155 | GRK1 | 0.32588119 |
156 | PRKCA | 0.32350445 |
157 | STK4 | 0.30545128 |
158 | MAPK12 | 0.30473131 |
159 | TIE1 | 0.30040490 |
160 | PAK3 | 0.29468146 |
161 | PDGFRA | 0.28436959 |
162 | STK10 | 0.27982851 |
163 | RET | 0.27270508 |
164 | MAP3K14 | 0.26331486 |
165 | AKT2 | 0.24258354 |
166 | CAMKK1 | 0.21869660 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.04484782 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.70834207 |
3 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.25109418 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.17799345 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.13925585 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65497173 |
7 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54721070 |
8 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.51661433 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37377034 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.30617256 |
11 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.24137568 |
12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.24061288 |
13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.15038128 |
14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09419111 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08737203 |
16 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05998360 |
17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.01199358 |
18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94309695 |
19 | DNA replication_Homo sapiens_hsa03030 | 1.87625487 |
20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.81622980 |
21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.80279878 |
22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.79670195 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78804694 |
24 | Peroxisome_Homo sapiens_hsa04146 | 1.78186234 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77425691 |
26 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.76948102 |
27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68765560 |
28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65435770 |
29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.64682007 |
30 | Bile secretion_Homo sapiens_hsa04976 | 1.63357197 |
31 | Mismatch repair_Homo sapiens_hsa03430 | 1.61257007 |
32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60178987 |
33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.56904977 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56298743 |
35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55998155 |
36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55374838 |
37 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.54584470 |
38 | Proteasome_Homo sapiens_hsa03050 | 1.54567350 |
39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52380645 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47601274 |
41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47529001 |
42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.47408150 |
43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42695790 |
44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.42602478 |
45 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41535484 |
46 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40826556 |
47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37954117 |
48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36857168 |
49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35707922 |
50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33419048 |
51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.33391141 |
52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23201585 |
53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22321337 |
54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18579135 |
55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13984826 |
56 | ABC transporters_Homo sapiens_hsa02010 | 1.13789809 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12890787 |
58 | Base excision repair_Homo sapiens_hsa03410 | 1.09540647 |
59 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.07848984 |
60 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07505686 |
61 | RNA polymerase_Homo sapiens_hsa03020 | 1.07052964 |
62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06269914 |
63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98154215 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97872153 |
65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97395158 |
66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.96890496 |
67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94989797 |
68 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.94545217 |
69 | RNA transport_Homo sapiens_hsa03013 | 0.94476065 |
70 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92065509 |
71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91839161 |
72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91247533 |
73 | Homologous recombination_Homo sapiens_hsa03440 | 0.84523023 |
74 | Cell cycle_Homo sapiens_hsa04110 | 0.82004444 |
75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81406326 |
76 | Spliceosome_Homo sapiens_hsa03040 | 0.81011112 |
77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79138409 |
78 | Protein export_Homo sapiens_hsa03060 | 0.78286058 |
79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75846518 |
80 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71978414 |
81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70324205 |
82 | * Lysine degradation_Homo sapiens_hsa00310 | 0.68060094 |
83 | Ribosome_Homo sapiens_hsa03010 | 0.67325595 |
84 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53895239 |
85 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50765500 |
86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47388205 |
87 | Purine metabolism_Homo sapiens_hsa00230 | 0.47026762 |
88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.44789272 |
89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42745197 |
90 | RNA degradation_Homo sapiens_hsa03018 | 0.41834048 |
91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41015107 |
92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40458211 |
93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38894074 |
94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38681199 |
95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37449441 |
96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35807246 |
97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34824663 |
98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34393693 |
99 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34213232 |
100 | Mineral absorption_Homo sapiens_hsa04978 | 0.33437887 |
101 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.29951182 |
102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.29482026 |
103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27872727 |
104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22747372 |
105 | Insulin resistance_Homo sapiens_hsa04931 | 0.21364383 |
106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14137764 |
107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.14053049 |
108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12418610 |
109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10527268 |
110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09053151 |
111 | Parkinsons disease_Homo sapiens_hsa05012 | 0.08830363 |
112 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.06246701 |
113 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.04879616 |
114 | Prion diseases_Homo sapiens_hsa05020 | 0.03475467 |
115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02486368 |
116 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1741409 |
117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1571526 |
118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1448488 |
119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1314271 |
120 | Pertussis_Homo sapiens_hsa05133 | -0.1230325 |
121 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1219379 |
122 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1185164 |
123 | Bladder cancer_Homo sapiens_hsa05219 | -0.1068952 |
124 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0891142 |
125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0718509 |
126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0626439 |
127 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0243588 |
128 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0164428 |
129 | Hepatitis C_Homo sapiens_hsa05160 | -0.0024751 |